TTUHSC Graduate School of Biomedical Sciences
HomeBiomedical SciencesFaculty and Staff

GSBS Faculty Details

Profile for Oriana Hawkins, PhD

Oriana Hawkins, PhD

  • Adjunct Assistant Professor
Office Phone: 325-670-0495 ext 109
Mail Address: 1325 Pine St
Abilene TX 79601


Dr. Hawkins has more than 16 years of research experience, ranging from immunoassay development for agribusiness to preclinical models of drug efficacy in cancer. She earned her doctoral degree in Microbiology and Immunology from the University of Oklahoma Health Sciences Center where she worked with companies such as Pure Protein, LLC, and Receptor Logic, Inc., to develop biopharmaceuticals. She completed an NIH sponsored postdoctoral fellowship in Cancer Biology at Vanderbilt University. Dr. Hawkins holds an appointment as Adjunct Assistant Professor of Immunotherapeutics and Biotechnology at Texas Tech University Health Sciences Center. Her primary role is that of Lab Director and Scientist at Experimmune, a Center for Immunotherapeutic Development.

Research Interests

. Hawkins' research interests include immunotherapeutic targeting of the tumor microenvironment, with particular focus on the HLA molecule and its role as a disease biomarker.

Selected Publications:

  • Liu, Y & Hawkins, Oriana & Vilgelm, A & Pawlikowski, J & Ecsedy, J & Sosman, J & Kelley, M & Richmond, A July (2015) Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models. Clinical cancer research : an official journal of the American Association for Cancer Research.
  • Weidanz, Jon & Doll, K & Mohana-Sundaram, S & Wichner, T & Lowe, Devin & Gimlin, S & Wawro Weidanz, D & Magnusson, R & Hawkins, Oriana March (2015) Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology. Journal of visualized experiments : JoVE, 97.
  • Vilgelm, A & Pawlikowski, J & Liu, Y & Hawkins, Oriana & Davis, T & Smith, J & Weller, K & Horton, L & McClain, C & Ayers, G & Turner, D & Essaka, D & Stewart, C & Sosman, J & Kelley, M & Ecsedy, J & Johnston, J & Richmond, A January (2015) Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Cancer research, 75, 1, 181-93.
  • Yang, J & Hawkins, Oriana & Barham, W & Gilchuk, P & Boothby, M & Ayers, G & Joyce, S & Karin, M & Yull, F & Richmond, A December (2014) Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response. Cancer research, 74, 24, 7274-84.
  • Kim, S & Pinto, A & Myers, N & Hawkins, Oriana & Doll, K & Kaabinejadian, S & Netland, J & Bevan, M & Weidanz, Jon & Hildebrand, W & Diamond, M & Hansen, T July (2014) A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. European journal of immunology, 44, 7, 1936-46.